TheStreet.com
GE Stock Is Flying: Here’s Why Its Best Prospect for Growth Is Aerospace
GE, now sans GE Healthcare Technologies , reaffirmed its fiscal year 2023 guidance with organic revenue growth still expected to post in the high-single-digit range, adjusted EPS still expected to land in between $1.60 and $1.95, and free cash flow generation of $3.4B to $4.2B. The firm went a step further in reaffirming guidance for both GE Aerospace and GE Vernova. For GE Aerospace, organic revenue growth is seen in the mid-to-high teens, operating profit is seen at $5.3B to $5.7B, and free cash flow is expected to grow.